Full-Time

Machine Learning Engineer

Elicit

Elicit

51-200 employees

AI-powered literature review and data extraction

Compensation Overview

$185k - $230k/yr

+ Equity

Oakland, CA, USA

Hybrid

Quarterly team retreats in SF Bay Area; remote work allowed within US time zones.

Category
AI & Machine Learning (1)
Required Skills
LLM
Requirements
  • A strong software engineering background and can build end-to-end systems, not just scripts or notebooks.
  • Fluency with language models to reason well about prompting, retrieval, evals, failure modes, and where (and how) finetuning is or isn’t worth it.
  • Strong product sense and likes turning fuzzy user problems into concrete things people can use.
  • An excitement to solve difficult, creative problems rather than narrow optimization on well-defined benchmarks.
  • Ability to move across backend, data, and model layers as needed.
  • Clear communication with product, design, domain experts, and other engineers.
  • Ability to use coding assistants effectively and thoughtfully, and has adapted their workflow to become much more effective with them.
Responsibilities
  • Turning messy, ambiguous research tasks into clear product experiences
  • Building interfaces and artifacts that help users understand, trust, and act on model outputs, thinking beyond the chat interface while leveraging full model capabilities
  • Combining language models with external tools, structured and unstructured data, and retrieval systems
  • Improving quality through building careful evaluations, truth-conducive model environments and tools, and targeted ML modeling where the impact is high
  • Agentic harnesses for target assessment, evidence synthesis, and experiment planning that allow models to provide guarantees about their processes
  • Data integrations across literature, scientific databases, customer data, and internal tools
  • APIs that customers can use in their own systems
  • Evaluation systems that help us understand whether a change actually improves user outcomes
  • Trust and transparency features, like source-quality signals, intermediate reasoning, and better ways to inspect and fix outputs
  • Build a target-assessment workflow that combines literature, genetics, chemistry, clinical, regulatory, and company data into a shareable artifact
  • Build experiment-planning and iteration tools that help researchers decide what to do next and learn from new results
  • Build evidence-monitoring workflows that keep teams up to date through alerts, briefs, and living reports
  • Build enterprise APIs and structured-output pipelines that plug Elicit into customers’ internal systems
  • Build interfaces that make it easier to inspect, trust, and correct model outputs
  • Build workflow-specific evals and quality systems that tell us whether a product change actually helped users
  • Improve extraction, reasoning, or search quality with better prompts, better system design, or finetuning when appropriate

Elicit is an AI-powered research assistant that speeds up complex scholarly workflows by using large language models to search a database of over 125 million papers through natural-language queries. It goes beyond keyword searches by finding semantically relevant studies, extracts specific data from papers, and compiles results into organized tables and summaries. Users can upload their own PDFs for analysis, with outputs grounded in verifiable sources to reduce AI hallucinations. The platform operates as a Public Benefit Corporation, serving individuals and large organizations while offering tiered freemium pricing to improve research efficiency and evidence-based decision making.

Company Size

51-200

Company Stage

Series A

Total Funding

$31M

Headquarters

Oakland, California

Founded

2023

Simplify Jobs

Simplify's Take

What believers are saying

  • Series A $22M at $100M valuation from Spark Capital fuels enterprise expansion.
  • 400,000 monthly users convert via freemium to millions in recurring revenue.
  • Genentech, Novartis partnerships drive life sciences R&D adoption rapidly.

What critics are saying

  • Perplexity Deep Research replicates features, steals 60-80% users in 6-12 months.
  • OpenAI ChatGPT Scholar undercuts freemium, erodes subscriptions in 3-6 months.
  • Semantic Scholar free tools commoditize extraction, collapse moat in 12-18 months.

What makes Elicit unique

  • Elicit automates systematic reviews, screening titles and extracting data 80% faster.
  • Clinical Trials feature launched 2026 targets pharma trial monitoring uniquely.
  • Public Benefit Corporation prioritizes societal reasoning over pure profit.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Flexible Work Hours

Remote Work Options

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Home Office Stipend

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

4%

2 year growth

0%
Elicit
Jul 23rd, 2025
Introducing Clinical Trials

Today Elicit is launching Clinical Trials in Elicit.

Elicit
Mar 18th, 2025
How we evaluated Elicit Systematic Review

Last month, Elicit introduced Elicit Systematic Review, a new AI workflow that allows researchers to find papers, screen titles and abstracts, and extract data from full-text papers in 80% less time, without compromising accuracy.

Elicit
Feb 28th, 2025
Elicit Raises $22M to Build the Most Trusted AI Platform for Evidence-Backed Decisions

Elicit has raised $22M in Series A funding at a $100M valuation led by Spark Capital and Footwork. Existing investors Fifty Years, Basis Set, and Mythos also participated, reinforcing their conviction in our mission to deploy AI to radically increase good reasoning in the world. Today, Elicit is used by

Elicit
Feb 26th, 2025
Elicit Secures $22M for AI Platform

Elicit has raised $22 million in Series A funding at a $100 million valuation, led by Spark Capital and Footwork, with participation from existing investors. Elicit, used by over 400,000 researchers monthly, aims to expand its AI platform beyond academic research to support evidence-based decision-making across industries. The funding will help Elicit build infrastructure for good reasoning as AI reshapes the global economy by 2027.

Elicit
Sep 25th, 2023
Elicit raises $9 million and becomes a public benefit corporation

We're excited to share that Elicit has raised $9 million in seed funding. Elicit was born at Ought, a non-profit research organization, and is now an independent public benefit corporation. Like Ought, our mission is to scale up good reasoning using machine learning, starting with researchers. Elicit is designed to